Schedule 13G ownership disclosure

CYBIN INC

Security class unavailable · CUSIP: 23256X100

Event date: 2023-09-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
18,950,000
Percent of class
8.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-23-004792
Form type
SC 13G
Filer
Helus Pharma Inc.
CIK
CIK 1833141
Filed
Sep 15, 2023
Reporting period
Sep 14, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub